ReviewPharmacology research & perspectives2025

Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System.

Maryann R Chapin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.